Uploaded October 2026 | Updated November 2026, 1 day ago
Affordable obesity and diabetes care were examined through prevention, essential medicines, and new GLP-1 treatments. Speakers debated financing, pooled procurement and lessons from HIV programs for expanding access in low- and middle-income countries. They stressed that integrated primary healthcare and meaningful patient involvement were essential to delivering equitable, affordable, and holistic care.
Moderator
• Katie Dain, NCD Alliance
Speakers
• Søren Brostrøm, World Health Organization (WHO)
• Hugo Dürr, Novo Nordisk A/S
• Kimberly Green, PATH
• Jayasree K. Iyer, Access to Medicine Foundation
• Peter Sands, The Global Fund to Fight AIDS, Tuberculosis and Malaria
• Mohammed Seyam, NCD Alliance
Explore related sessions:
• The Future of Metabolic Health, Liver Disease and Related NCDs youtube.com/live/vUGiLTgJSRE
• Strengthening NCD Prevention and Stroke Management Across the Care Pathway youtube.com/live/H9jgEPn5yaQ
The World Health Summit 2026 took place October 11–13 in Berlin and online, bringing together leaders and changemakers from science, politics, civil society, and the private sector to address key global health priorities.
Learn more: worldhealthsummit.org
────────────────────────
Chapters:
00:00 Introduction: Rethinking Equitable Access to Obesity and Diabetes Care
05:25 What Is the Global Burden of Diabetes and Obesity?
07:35 Why Is Access to Insulin Still Unequal?
11:00 What Are the Barriers to Diabetes Diagnosis and Monitoring?
14:00 Can New Obesity Treatments Improve Equitable Access?
16:25 Audience Poll: What Should Be Prioritized to Improve NCD Care?
19:55 What Can WHO Do to Improve Access to Essential Medicines?
22:20 Why Must People Living With NCDs Shape Healthcare Solutions?
26:25 How Is the Pharmaceutical Industry Improving Access to Insulin?
31:05 Can the Global Fund Model Help Expand NCD Care?
38:35 How Can Countries Finance Equitable Obesity and Diabetes Care?
45:30 How Can Partnerships Improve Access to Obesity Treatments?
50:30 Should Governments Focus More on Prevention or New Medicines?
56:00 How Can Health Systems Address the Root Causes of Obesity?
1:02:00 How Can Patient-Centered Care Improve Access?
1:06:40 What Role Could the Global Fund Play in NCD Care?
1:11:00 Audience Q&A: Access, Affordability, and Prevention
1:18:15 How Can Treatment Access Be Improved for People Living With HIV?
1:23:00 How Can Countries Sustain Investments in NCD Care?
1:27:00 Final Reflections: What Needs to Change in Global NCD Care?
1:32:10 Closing Remarks
Affordable obesity and diabetes care were examined through prevention, essential medicines, and new GLP-1 treatments. Speakers debated financing, pooled procurement and lessons from HIV programs for expanding access in low- and middle-income countries. They stressed that integrated primary healthcare and meaningful patient involvement were essential to delivering equitable, affordable, and holistic care.
Moderator
• Katie Dain, NCD Alliance
Speakers
• Søren Brostrøm, World Health Organization (WHO)
• Hugo Dürr, Novo Nordisk A/S
• Kimberly Green, PATH
• Jayasree K. Iyer, Access to Medicine Foundation
• Peter Sands, The Global Fund to Fight AIDS, Tuberculosis and Malaria
• Mohammed Seyam, NCD Alliance
Explore related sessions:
• The Future of Metabolic Health, Liver Disease and Related NCDs youtube.com/live/vUGiLTgJSRE
• Strengthening NCD Prevention and Stroke Management Across the Care Pathway youtube.com/live/H9jgEPn5yaQ
The World Health Summit 2026 took place October 11–13 in Berlin and online, bringing together leaders and changemakers from science, politics, civil society, and the private sector to address key global health priorities.
Learn more: worldhealthsummit.org
────────────────────────
Chapters:
00:00 Introduction: Rethinking Equitable Access to Obesity and Diabetes Care
05:25 What Is the Global Burden of Diabetes and Obesity?
07:35 Why Is Access to Insulin Still Unequal?
11:00 What Are the Barriers to Diabetes Diagnosis and Monitoring?
14:00 Can New Obesity Treatments Improve Equitable Access?
16:25 Audience Poll: What Should Be Prioritized to Improve NCD Care?
19:55 What Can WHO Do to Improve Access to Essential Medicines?
22:20 Why Must People Living With NCDs Shape Healthcare Solutions?
26:25 How Is the Pharmaceutical Industry Improving Access to Insulin?
31:05 Can the Global Fund Model Help Expand NCD Care?
38:35 How Can Countries Finance Equitable Obesity and Diabetes Care?
45:30 How Can Partnerships Improve Access to Obesity Treatments?
50:30 Should Governments Focus More on Prevention or New Medicines?
56:00 How Can Health Systems Address the Root Causes of Obesity?
1:02:00 How Can Patient-Centered Care Improve Access?
1:06:40 What Role Could the Global Fund Play in NCD Care?
1:11:00 Audience Q&A: Access, Affordability, and Prevention
1:18:15 How Can Treatment Access Be Improved for People Living With HIV?
1:23:00 How Can Countries Sustain Investments in NCD Care?
1:27:00 Final Reflections: What Needs to Change in Global NCD Care?
1:32:10 Closing Remarks










